Skip to main content
SpringerLink
Log in

Nouvelles cibles thérapeutiques du sepsis — Triggering receptor expressed on myeloid cells-1: une nouvelle cible thérapeutique au cours des pathologies inflammatoires

Novel therapeutic targets in sepsis — Triggering receptor expressed on myeloid cells-1: a novel therapeutic target in inflammatory disease

  • Enseignement Supérieur en Réanimation Fondamental
  • Published:
Réanimation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Diefenbach A, Raulet DH (2003) Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 15:37–44

    Article  CAS  PubMed  Google Scholar 

  2. Kubagawa H, Burrows PD, Cooper MD (1997) A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA 94:5261–5266

    Article  CAS  PubMed  Google Scholar 

  3. Cantoni C, Bottino C, Vitale M, et al (1999) NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 189:787–796

    Article  CAS  PubMed  Google Scholar 

  4. Dietrich J, Cella M, Seiffert M, et al (2000) Cutting edge: signal-regulatory protein β1 is a DAP12-associated activating receptor expressed on myeloid cells. J Immunol 164:9–12

    CAS  PubMed  Google Scholar 

  5. Bouchon A, Dietrich J, Colonna M (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164:4991–4995

    CAS  PubMed  Google Scholar 

  6. Daws MR, Lanier LL, Seaman WE, Ryan JC (2001) Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur J Immunol 31:743–791

    Article  Google Scholar 

  7. Chung DH, Seaman WE, Daws MR (2002) Characterization of TREM-3, an activating receptor on mouse macrophages: definition of a family of single Ig domain receptors on mouse chromosome 17. Eur J Immunol 32:59–66

    Article  CAS  PubMed  Google Scholar 

  8. Bouchon A, Hernandez-Munain C, Cella M, Colonna M (2001) A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 194:1111–1122

    Article  CAS  PubMed  Google Scholar 

  9. Bouchon A, Facchetti F, Weigand MA, Colonna M (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410:1103–1107

    Article  CAS  PubMed  Google Scholar 

  10. Colonna M, Fachetti F (2003) TREM-1: a new player in acute inflammatory responses. J Infect Dis 187(Suppl 2):S397–S401

    Article  CAS  PubMed  Google Scholar 

  11. Bleharski JR, Kiessler V, Buonsanti C, et al (2003) A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 170:3812–3818

    CAS  PubMed  Google Scholar 

  12. Radsak MP, Salih HR, Rammensee H, Schild H (2004) Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol 172:4956–4963

    CAS  PubMed  Google Scholar 

  13. Gibot S, Kolopp-Sarda MN, Béné MC, et al (2004) A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 200:1419–1426

    Article  CAS  PubMed  Google Scholar 

  14. Lanier LL, Bakker AB (2000) The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol Today 21:611–614

    Article  CAS  PubMed  Google Scholar 

  15. Sharif O, Knapp S (2008) From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 213:701–713

    Article  CAS  PubMed  Google Scholar 

  16. Fortin CF, Lesur O, Fulop T (2007) Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4. Int Immunol 19:41–50

    Article  CAS  PubMed  Google Scholar 

  17. Haselmayer P, Grosse-Hovest L, von Landenberg P, et al (2007) TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 110:1029–1035

    Article  CAS  PubMed  Google Scholar 

  18. McVicar DW, Taylor LS, Gosselin P, et al (1998) DAP12-mediated signal transduction in natural killer cells: a dominant role for the Syk protein-tyrosine kinase. J Biol Chem 273:32934–32942

    Article  CAS  PubMed  Google Scholar 

  19. Tessarz AS, Cerwenka A (2008) The TREM-1/DAP12 pathway. Immunol Lett 116:111–116

    Article  CAS  PubMed  Google Scholar 

  20. Hara H, Ishihara C, Takeuchi A, et al (2007) The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat Immunol 8:619–629

    Article  CAS  PubMed  Google Scholar 

  21. Hara H, Saito T (2009) CARD9 versus CARMA1 in innate and adaptive immunity. Trends in Immunol 30:234–242

    Article  CAS  Google Scholar 

  22. Dower K, Ellis DK, Saraf K, et al (2008) Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. J Immunol 180:3520–3534

    CAS  PubMed  Google Scholar 

  23. Ornatowska M, Azim AC, Wang X, et al (2007) Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol 293:L1377–L1384

    Article  CAS  PubMed  Google Scholar 

  24. Kelker MS, Foss TR, Peti W, et al (2004) Crystal structure of human triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.47 A. J Mol Biol 342:1237–1248

    Article  CAS  PubMed  Google Scholar 

  25. Kelker MS, Debler EW, Wilson IA (2004) Crystal structure of mouse triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.76 A. J Mol Biol 344:1175–1181

    Article  CAS  PubMed  Google Scholar 

  26. Knapp S, Gibot S, de Vos A, et al (2004) Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol 173:7131–7134

    CAS  PubMed  Google Scholar 

  27. Ramanathan B, Minton JE, Ross CR, Blecha F (2005) Cloning of porcine triggering receptor expressed on myeloid cells-1 (TREM-1) and its induction by lipopolysaccharide, peptidoglycan, and Salmonella enterica serovar Typhimurium infection. Dev Comp Immunol 29:1–7

    Article  CAS  PubMed  Google Scholar 

  28. Gibot S, Massin F, Le Renard P, et al (2005) Surface and soluble triggering receptor expressed on myeloid cells-1: expression patterns in murine sepsis. Crit Care Med 33:1787–1793

    Article  CAS  PubMed  Google Scholar 

  29. Zheng H, Heiderscheidt CA, Joo M, et al (2010) MYD88-dependent and -independent activation of TREM-1 via specific TLR ligands. Eur J Immunol 40:162–171

    Article  CAS  PubMed  Google Scholar 

  30. Zeng H, Ornatowska M, Joo MS, Sadikot RT (2007) TREM-1 expression in macrophages is regulated at transcriptional level by NF-kappaB and PU.1. Eur J Immunol 37:2300–2308

    Article  CAS  PubMed  Google Scholar 

  31. Gómez-Piña V, Soares-Schanoski A, Rodríguez-Rojas A, et al (2007) Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 179:4065–4073

    PubMed  Google Scholar 

  32. Wong-Baeza I, González-Roldán N, Ferat-Osorio E, et al (2006) Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clin Exp Immunol 145:448–455

    Article  CAS  PubMed  Google Scholar 

  33. Hamerman JA, Tchao NK, Lowell CA, Lanier LL (2005) Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 6:579–586

    Article  CAS  PubMed  Google Scholar 

  34. Hamerman JA, Jarjoura JR, Humphrey MB, et al (2006) Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 77:2051–2055 (2006)

    Google Scholar 

  35. Gibot S, Buonsanti C, Massin F, et al (2006) Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect Immun 74:2823–2830

    Article  CAS  PubMed  Google Scholar 

  36. Gibot S, Alauzet C, Massin F, et al (2006) Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats. J Infect Dis 194:975–983

    Article  CAS  PubMed  Google Scholar 

  37. Gibot S, Massin F, Marcou M, et al (2007) TREM-1 promotes survival during septic shock in mice. Eur J Immunol 37:456–466

    Article  CAS  PubMed  Google Scholar 

  38. Gibot S, Cravoisy A, Levy B, et al (2004) Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 350:451–458

    Article  CAS  PubMed  Google Scholar 

  39. Wiersinga WJ, Veer CT, Wieland CW, et al (2007) Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis. J Infect Dis 196:1707–1716

    Article  CAS  PubMed  Google Scholar 

  40. Jarrar D, Chaudry IH, Wang P (1999) Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches. Int J Mol Med 4:575–583

    CAS  PubMed  Google Scholar 

  41. Hierholzer C, Harbrecht B, Menezes JM, et al (1998) Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 187:917–928

    Article  CAS  PubMed  Google Scholar 

  42. Meng ZH, Dyer K, Billiar TR, et al (2001) Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am J Physiol Cell Physiol 280:C343–C351

    CAS  PubMed  Google Scholar 

  43. Meldrum DR, Shenkar R, Sheridan BC, et al (1997) Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart. J Mol Cell Cardiol 29:2849–2854

    Article  CAS  PubMed  Google Scholar 

  44. Samy TS, Ayala A, Catania RA, et al (1998) Trauma-hemorrhage activates signal transduction pathways in mouse splenic T cells. Shock 9:443–450

    Article  CAS  PubMed  Google Scholar 

  45. Shimizu T, Tani T, Endo Y, et al (2002) Elevation of plasma peptidoglycan and peripheral blood neutrophil activation during hemorrhagic shock: plasma peptidoglycan reflects bacterial translocation and may affect neutrophil activation. Crit Care Med 30:77–82

    Article  CAS  PubMed  Google Scholar 

  46. Shimizu T, Yu HP, Hsieh YC, et al (2007) Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway. Ann Surg 245:297–304

    Article  PubMed  Google Scholar 

  47. Macias CA, Chiao JW, Xiao J, et al (2007) Treatment with a novel hemigramicidin-TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shock. Ann Surg 245:305–314

    Article  PubMed  Google Scholar 

  48. Bini R, Olivero G, Trombetta A, et al (2008) Effects of dimethyl sulfoxide, pyrrolidine dithiocarbamate, and methylprednisolone on nuclear factor-kappaB and heat shock protein 70 in a rat model of hemorrhagic shock. J Trauma 64:1048–1054

    Article  CAS  PubMed  Google Scholar 

  49. Gibot S, Massin F, Alauzet C, et al (2009) Effects of the TREM-1 pathway modulation during hemorrhagic shock in rats. Shock 32:633–637

    Article  PubMed  Google Scholar 

  50. Oldenburg WA, Lau LL, Rodenberg TJ, et al (2004) Acute mesenteric ischemia: a clinical review. Arch Intern Med 164:1054–1062

    Article  PubMed  Google Scholar 

  51. Victoni T, Coelho FR, Soares AL, et al (2010) Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway. Med Microbiol Immunol 199:35–42

    Article  CAS  PubMed  Google Scholar 

  52. Suzuki T, Yamashita K, Jomen W, et al (2008) The novel NFkappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats. J Surg Res 149:69–75

    Article  CAS  PubMed  Google Scholar 

  53. Gibot S, Massin F, Alauzet C, et al (2008) Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats. Crit Care Med 36:504–510

    Article  CAS  PubMed  Google Scholar 

  54. Pamuk ON, Lapchak PH, Rani P, et al (2010) Spleen tyrosine kinase inhibition prevents tissue damage after ischemia reperfusion injury. Am J Physiol Gastrointest Liver Physiol doi:10.1152/ajpgi.00198.2010

  55. Ferat-Osorio E, Wong-Baeza I, Esquivel-Callejas N, et al (2009) Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Crit Care 13:R69

    Article  PubMed  Google Scholar 

  56. Swaroop VS, Chari ST, Clain JE (2004) Severe acute pancreatitis. JAMA 291:2865–2868

    Article  CAS  PubMed  Google Scholar 

  57. Yasuda T, Takeyama Y, Ueda T, et al (2008) Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Crit Care Med 36:2048–2053

    Article  CAS  PubMed  Google Scholar 

  58. Wang D, Qin R, Liu Z, et al (2004) Expression of TREM-1 mRNA in acute pancreatitis. World J Gastroenterol 10:2744–2746

    CAS  PubMed  Google Scholar 

  59. Kamei K, Yasuda T, Ueda T, et al (2010) Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis. J Hepatobiliary Pancreat Sci 17:305–312

    Article  PubMed  Google Scholar 

  60. Schenk M, Bouchon A, Seibold F, Mueller C (2007) TREM-1: expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest 117:3097–3106

    Article  CAS  PubMed  Google Scholar 

  61. Park JJ, Cheon JH, Kim BY, et al (2009) Correlation of serumsoluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease. Dig Dis Sci 54:1525–1531

    Article  CAS  PubMed  Google Scholar 

  62. Kuai J, Gregory B, Hill A, et al (2009) TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines. Rheumatology (Oxford) 48:1352–1358

    Article  CAS  Google Scholar 

  63. Collins CE, La DT, Yang HT, et al (2009) Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis 68:1768–1774

    Article  CAS  PubMed  Google Scholar 

  64. Murakami Y, Akahoshi T, Aoki N, et al (2009) Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis. Arthritis Rheum 60:1615–1623

    Article  CAS  PubMed  Google Scholar 

  65. Sharma SM, Choi D, Planck SR, et al (2009) Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles. Arthritis Res Ther 11:R168

    Article  PubMed  Google Scholar 

  66. Ratjen FA (2009) Cystic fibrosis: pathogenesis and future treatment strategies. Respir Care 54:595–605

    Article  PubMed  Google Scholar 

  67. del Fresno C, Gómez-Piña V, Lores V, et al (2008) Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism. PLoS ONE 3:e2667

    Article  PubMed  Google Scholar 

  68. del Fresno C, García-Rio F, Gómez-Piña V, et al (2009) Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 182:6494–6507

    Article  PubMed  Google Scholar 

  69. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

    Article  CAS  PubMed  Google Scholar 

  70. van Kempen LCL, de Visser KE, Coussens LM (2006) Inflammation, proteases and cancer. Eur J Cancer 42:728–734

    Article  PubMed  Google Scholar 

  71. Johansson M, Tan T, de Visser KE, Coussens LM (2007) Immune cells as anti-cancer therapeutic targets and tools. J Cell Biochem 101:918–926

    Article  CAS  PubMed  Google Scholar 

  72. Ho CC, Liao WY, Wang CY, et al (2008) TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. Am J Respir Crit Care Med 177:763–770

    Article  CAS  PubMed  Google Scholar 

  73. Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991–1045

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Groupe Choc, contrat Avenir Inserm, Faculté de Médecine, 9 avenue de la Forêt de Haye, 54500, Vandoeuvre-lès-Nancy, France

    M. Derive & S. Gibot

  2. Laboratoire d’immunologie, hôpital Brabois, CHU de Nancy, 54500, Vandoeuvre-lès-Nancy, France

    F. Massin

  3. Service de réanimation médicale, hôpital central, 29, avenue du Maréchal-de-Lattre-de-Tassigny, F-54035, Nancy cedex, France

    S. Gibot

Authors
  1. M. Derive
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Massin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Gibot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Derive.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Derive, M., Massin, F. & Gibot, S. Nouvelles cibles thérapeutiques du sepsis — Triggering receptor expressed on myeloid cells-1: une nouvelle cible thérapeutique au cours des pathologies inflammatoires. Réanimation 20 (Suppl 2), 456–462 (2011). https://doi.org/10.1007/s13546-010-0135-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13546-010-0135-9

Search

Navigation